PCSK9 and fatty liver disease: Furthermore, given recent studies showing that serum PCSK9s areinvolved in the pathogenesis of hepatic steatosis and alcohol-inducedinflammation [23, 24], PCSK9 inhibitors are increasingly utilized and expected toplay a protective role in liver diseases.